ArticleJournal of microbiology & biology education2026
Engaging students in an AI-driven RNA drug design research project through a crowd science-infused learning approach.
Article in Journal of microbiology & biology education, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The rapid growth of RNA therapeutics and artificial intelligence (AI) has transformed antiviral drug discovery and created an urgent need for interdisciplinary training that links computational methods with authentic virology research. Despite this, undergraduate and postgraduate curricula rarely provide students with opportunities to contribute directly to an active AI-driven drug design research pipeline. To address this gap, we designed a unique 5-day, non-wet-lab workshop that immerses both undergraduate and postgraduate coursework students in an ongoing research project aimed at developing deep learning (DL) models for small interfering RNA (siRNA) antiviral drug design. Our workshop is uniquely distinct from existing course-based undergraduate research experiences (CUREs), whereby we adopt a crowd-science teaching approach in which students collaboratively build a genuine DL tool producing outputs that directly feed into an in-house AI platform under active development. In this
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.